| |
n
|
Min
|
Q1
|
Median
|
Q3
|
Max
|
Mean
|
SD
|
|---|
|
GCT main group
|
165
|
3.4
|
10.50
|
15.80
|
24.40
|
142
|
19.63
|
15.56
|
|
Cohort 2
|
84
|
3.1
|
10.50
|
19.15
|
25.90
|
85.1
|
21.27
|
14.54
|
|
Cohort 3
|
237
|
3.4
|
11.00
|
18.90
|
26.50
|
148.1
|
22.30
|
17.38
|
- median median 25OHD serum levels, mean: mean 25OHD serum level values, Q1 first quartile, Q3 third quartile, SD standard deviation
- cohort 2 denotes control group consisting of patients with non-neoplastic scrotal diseases; cohort 3 denotes control group 2 consisting of male urologic patients with non-testicular and non-neoplastic diseases
- P = 0.1797 Kruskal Wallis Test for over-all comparison of GCT main group with the two other cohorts
